 "Image via Shutterstock")
CHENNAI PETROLEUM CORPORATION (Rs 201.25)
Support at Rs 199 below Rs 197.50. Resistance is at Rs 205.30 above Rs 209. (Buy for intraday with a stoploss below Rs 197.50)
[ABV MOVING AVERAGES + MACD BUY + NEW HIGH + VOLUME JUMP]
PANACEA BIOTEC (Rs 153.50)
Support at Rs 151.10 below Rs 149.35. Resistance is at Rs 156.90 above Rs159.70. (Buy for intraday with a stoploss below Rs 149.35)
[VOLUME JUMP + ABV MOVING AVERAGES + MACD BUY]
EMPEE DISTILLERIES (Rs 86.65)
Support at Rs 85 below Rs 83.25. Resistance is at Rs 89.50 above Rs 92. (Buy for intraday with a stoploss below Rs 83.25)
[STOCHASTICS BUY + ABV MOVING AVERAGES + VOLUME RISE + NEW HIGH]
DALMIA BHARAT SUGAR AND INDUSTRIES (Rs 66.55)
Support at Rs 64.10 below Rs 63.75. Resistance is at Rs 68.25 above Rs 69.65 (Buy for intraday with a stoploss below Rs 63.75)
[STOCHASTICS BUY + VOLUME JUMP+ ABV MOVING AVERAGES]
HIKAL (Rs 164.20)
Support at Rs161 below Rs 160.25. Resistance is at Rs 167.30 above Rs 169.50. (Buy for intraday with a stoploss below Rs 160.25)
[MACD & STOCHASTICS BUY + ABV MOVING AVERAGES + VOLUME JUMP + NEW HIGH]
Disclaimer: This report has been prepared by Geojit BNP Paribas Financial Services Limited (GBNPP), here in after referred to as GBNPP. GBNPP, a publicly listed company, is engaged in services of retail broking, credit, portfolio management and marketing investment products including mutual funds, life and general insurance and properties. Each recipient of this report should make such investigation as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this report (including the merits and risks involved). This document is not for public distribution and has been furnished to you solely for your information and must not be reproduced or redistributed to any other person. Persons into whose possession this document may come are required to observe these restrictions. Opinion expressed herein is our current opinion as of the date appearing on this report only. While we endeavor to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance, or other reasons that prevent us from doing so. Prospective investors and others are cautioned
